2019
Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults
Sobieraj DM, Martinez BK, Hernandez AV, Coleman CI, Ross JS, Berg KM, Steffens DC, Baker WL. Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults. Journal Of The American Geriatrics Society 2019, 67: 1571-1581. PMID: 31140587, DOI: 10.1111/jgs.15966.Peer-Reviewed Original ResearchConceptsSerotonin-norepinephrine reuptake inhibitorsSelective serotonin reuptake inhibitorsMajor depressive disorderOverall adverse eventsAdverse eventsYears of ageStudy withdrawalAcute phaseReuptake inhibitorsObservational studyAdverse effectsChoice of antidepressantSerious adverse eventsAcute treatment phaseNorepinephrine reuptake inhibitorsSerotonin reuptake inhibitorsSpecific adverse eventsComparative long-term studiesNonpharmacologic therapiesContinuation treatmentPatients 65Pharmacologic treatmentQTc prolongationMore fallsOutpatient setting
2013
Medical school gift restriction policies and physician prescribing of newly marketed psychotropic medications: difference-in-differences analysis
King M, Essick C, Bearman P, Ross JS. Medical school gift restriction policies and physician prescribing of newly marketed psychotropic medications: difference-in-differences analysis. The BMJ 2013, 346: f264. PMID: 23372175, PMCID: PMC3623604, DOI: 10.1136/bmj.f264.Peer-Reviewed Original ResearchMeSH KeywordsAntidepressive AgentsAntipsychotic AgentsCase-Control StudiesCentral Nervous System StimulantsCyclohexanolsDesvenlafaxine SuccinateDextroamphetamineDrug IndustryGift GivingHealth Care SectorHumansInterprofessional RelationsIsoxazolesMarketing of Health ServicesOrganizational PolicyPaliperidone PalmitatePractice Patterns, Physicians'Psychotropic DrugsPyrimidinesSchools, MedicalUnited StatesConceptsPsychotropic medicationsSubsequent prescribing behaviorPhysician prescribingPsychotropic classesOlder antipsychoticsPrescribing behaviorMAIN OUTCOMEMedicationsMedical schoolsPrescribingPhysiciansAntipsychoticsRestriction policiesDesvenlafaxinePaliperidoneStimulantsUS medical schoolsExposureLonger exposureAntidepressantsCohort